Hanmi Pharmaceutical Senior Vice President Choi In-young, head of the R&D center, speaks to Korean media outlets at a press ...

Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss according to a University of Illinois professor. GLP-1 medications were originally intended to treat type 2 diabetes, but ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Eli Lilly trims Q4 guidance but maintains optimism with promising drugs like Zepbound for sleep apnea and global launches ...

The podcast features Numerator Chief Economist Leo Feler, who talks about the potential impact of GLP-1 drugs like Ozempic ...

Medical experts proposed a radical overhaul of how obesity is diagnosed, moving away from relying on body mass alone and ...

Investing.com -- Bernstein analysts highlighted a more attractive valuation for Novo Nordisk (NYSE: NVO) following recent ...

A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.

Calling people obese is medically "flawed" - and the definition should be split into two, a report from global experts says.

As the temperatures drop below 10C, drying clothes in the cold can be tricky. But you don't necessarily need to use a tumble ...

Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...